BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Active filters

Product: Clarithromycin

Presentation	Product	Chemical substance	Chapter	Items dispensed
Clarithromycin 500mg tablets 0501050B0AAADAD	Clarithromycin	Clarithromycin	Infections	307,901
Clarithromycin 125mg/5ml oral suspension 0501050B0AAABAB	Clarithromycin	Clarithromycin	Infections	44,752
Clarithromycin 250mg tablets 0501050B0AAAAAA	Clarithromycin	Clarithromycin	Infections	35,057
Clarithromycin 250mg/5ml oral suspension 0501050B0AAAHAH	Clarithromycin	Clarithromycin	Infections	27,436
Clarithromycin 500mg modified-release tablets 0501050B0AAAEAE	Clarithromycin	Clarithromycin	Infections	1,187
Clarithromycin 250mg granules for oral suspension sachets 0501050B0AAAFAF	Clarithromycin	Clarithromycin	Infections	47
Clarithromycin 500mg powder for solution for infusion vials 0501050B0AAACAC	Clarithromycin	Clarithromycin	Infections	2
Clarithromycin 125mg granules for oral suspension sachets 0501050B0AAAGAG	Clarithromycin	Clarithromycin	Infections	No data available
Clarithromycin 125mg granules for oral suspension straws 0501050B0AAAKAK	Clarithromycin	Clarithromycin	Infections	No data available
Clarithromycin 187.5mg granules for oral suspension straws 0501050B0AAALAL	Clarithromycin	Clarithromycin	Infections	No data available
Clarithromycin 250mg granules for oral suspension straws 0501050B0AAAMAM	Clarithromycin	Clarithromycin	Infections	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.